ABVC BioPharma, Inc.
Hedge Funds Holdings
Last updated:
ABVC BioPharma, Inc.‘s stocks are currently a part of 3 hedge funds’ portfolios, which represents 0.19% of the total amount of its stocks outstanding. This makes up a total of 56.02K shares of ABVC BioPharma, Inc.. Compared to the previous quarter, the number fell by -90.71% or -547.12K shares fewer. As for the holding position changes, 66.67% (2) of current hedge fund investors increased the number of shares held, 33.33% (1) of current holders sold a part of the shares held, and 66.67% (2) closed the holdings completely.
Hedge funds holding ABVC BioPharma (Q3 2021 – Q1 2023)
| Q3 2021 | 9 |
|---|---|
| Q4 2021 | 5 |
| Q1 2022 | 4 |
| Q2 2022 | 5 |
| Q3 2022 | 9 |
| Q4 2022 | 9 |
| Q1 2023 | 3 |
Hedge funds changes in ABVC BioPharma positions (Q3 2021 – Q1 2023)
| Q3 2021 | 9 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q4 2021 | 2 | 2 | 0 | 6 | -5 |
| Q1 2022 | 0 | 1 | 1 | 1 | 1 |
| Q2 2022 | 3 | 0 | 0 | 2 | 0 |
| Q3 2022 | 5 | 2 | 1 | 1 | 0 |
| Q4 2022 | 3 | 2 | 3 | 3 | -2 |
| Q1 2023 | 0 | 2 | 1 | 2 | -2 |
Top 50 hedge fund holders of ABVC BioPharma, Inc. (NASDAQ:ABVC)
| Hedge fund | Value | Shares owned | Portfolio share |
|---|---|---|---|
| VANGUARD GROUP INC | 330K | 375.14K | 0.000% |
| GEODE CAPITAL MANAGEMENT, LLC | 122K | 139.65K | 0.000% |
| BLACKROCK INC. Larry Fink | 34K | 38.66K | 0.000% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 25K | 28.29K | 0.000% |
| NORTHERN TRUST CORP | 16K | 18.42K | 0.000% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 13K | 15.09K | 0.000% |
| CITADEL ADVISORS LLC Ken Griffin | 11K | 12.61K | 0.000% |
| MILLENNIUM MANAGEMENT LLC Israel Englander | 10K | 11.01K | 0.000% |
| JANE STREET GROUP, LLC | 10K | 11.37K | 0.000% |
| ARMISTICE CAPITAL, LLC | 0 | 0 | 0.000% |